安科生物: 董事会决议公告

Core Points - The company held its 21st meeting of the 8th Board of Directors on August 20, 2025, with all 12 directors present, confirming compliance with legal and regulatory requirements [1][2] - The board approved the 2025 semi-annual report and its summary, which will be published on designated information disclosure websites [1][2] - The board also approved the repurchase and cancellation of 276,500 restricted stocks that do not meet incentive conditions, representing 0.02% of the company's total share capital [2]